Menu
Recruiting NCT06874426

The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction

Observational Meningioma Pituitary Disease Pituitary Adenoma Craniopharyngioma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Endoscopic endonasal skull base surgery.
Who it may be relevant to
Registry conditions: Meningioma, Pituitary Disease, Pituitary Adenoma, Craniopharyngioma. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium, Germany, Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

In this study, the research team will investigate the incidence and etiology of olfactory dysfunction following endoscopic endonasal skull base surgery, by combining clinical assessments with histomolecular analysis.

Detailed description

The incidence of olfactory dysfunction following endoscopic endonasal skull base surgery remains unclear in current research, and the results vary widely. Additionally, the pathophysiology of this postoperative olfactory dysfunction and the impact of this surgery on the trigeminal system has not been investigated to date. In this study, the investigators developed a state-of-the-art clinical pipeline with olfactory and trigeminal assessments, prior to and following endoscopic endonasal skull base surgery. Furthermore, the investigators will collect surgical waste tissue from the posterior septal mucosa, which is removed during this procedure to gain access to the sphenoid sinus and the (para)sellar region. By performing histomolecular analysis, the research group aims to elucidate the pathophysiology of olfactory dysfunction following this surgery.

Interventions

  • Procedure Endoscopic endonasal skull base surgery
    This intervention will be performed as part of the standard-of-care for patients scheduled for endoscopic endonasal skull base surgery for lesions in the (para)sellar region

Primary outcome measures

  • Incidence of olfactory dysfunction [Time frame: From enrollment to the last evaluation 6 months postoperatively]
  • Incidence of trigeminal dysfunction [Time frame: From enrollment to the last evaluation 6 months postoperatively]
  • Etiology of olfactory and trigeminal dysfunction following endoscopic endonasal skull base surgery [Time frame: Until the end of study (at 3 years)]
Secondary outcome measures (1)
  • Risk factors for olfactory dysfunction following endoscopic endonasal skull base surgery [Time frame: From enrollment to the last evaluation 6 months postoperatively]

Eligibility criteria

Inclusion criteria

  • Adult patients scheduled for endoscopic endonasal skull base surgery

Exclusion criteria

  • Pre-existing anosmia
  • Patients has a history of previous endoscopic endonasal skull base surgery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Belgium · 1 center
  • KU Leuven — Leuven
Germany · 1 center
  • Max Planck Research Unit for Neurogenetics — Frankfurt am Main
Netherlands · 1 center
  • Leiden University Medical Center — Leiden

Identifiers

NCT: NCT06874426 · S69823

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗